Advanced Search

Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2012 October;64(5) > Minerva Pediatrica 2012 October;64(5):545-7



A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry

Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532

Frequency: Bi-Monthly

ISSN 0026-4946

Online ISSN 1827-1715


Minerva Pediatrica 2012 October;64(5):545-7


Dapsone treatment in a girl with severe chronic thrombocytopenic purpura. Does it work? Do not touch it!

Pusiol A., Nocerino A., Passone E., Tenore A.

Pediatric Clinic, Udine University Hospital, Udine, Italy

Dapsone has been shown to be effective in treating immune thrombocytopenic purpura (ITP) in adults. In children the experience is limitated. We describe our experience using dapsone in a female with refractory, symptomatic ITP who suffered intracranic haemorrhage and massive gastric bleeding. After treatment platelet counts was more than 100 x 103/μL, and reached 1000x103/μL. Discontinuation resulted in a rapid decrease in platelet counts, with severe intracranial haemorrhage (ICH). The recovery of dapsone led the platelets count to lower values. We suggest that treatment should not be discontinued in responders, at least in children with symptomatic ITP. Additional studies of dapsone in children are warranted.

language: English


top of page